On Wednesday, 1/8/2020 Marijuana Stock & beer and wine distributor Constellation Brands (STZ) reported their earnings for the third quarter of 2019, which beat expectations while raising its full-year guidance as a decline in fear of losing marijuana stock investments was relieved. Constellation Brands (STZ) stock began to run, up.
Constellation Brands Releases Earnings
Estimates: Wall Street anticipated Constellation Brands earnings per share to drop slightly by over 20% to $1.85. Revenue for the parent of Corona is seen declining by 0.9% to $1.955 billion.
Results: EPS of $2.14 or $2.39 after eliminating equity losses from Canopy Growth on its income of $2 billion.
In Q3, Constellation Brands (STZ) realized a $534 million reduction in the average value of Canadian marijuana farmer Canopy Growth (CGC), (WEED) whose stock has dipped back from April 2019, that’s a drop from an $839 million decrease in Q2.
Outlook: The company raised its full-year EPS to $9.45-$9.55 from a prior of $9-$9.20.
Marijuana Stocks | Constellation Brands (STZ) | Canopy Growth (CGC), (WEED)
Constellation Brands stock went up 3% to $189.00 in premarket trading on Tuesday, 1/7/2020. However, (STZ) broke support at its 50-day line on the same day. That critical level of market support crossed below Constellation’s 200-day line in December 2019, which can be a bearish sign. All this took place while Canopy Growth (CGC), (WEED) stock increased by 1% early.
Constellation Brands (STZ) shares seesawed through 2019, amid challenges in the wine industry and a $4 billion investment in Canopy Growth (CGC), (WEED). Marijuana stock (STZ) has a sub-par 43 Composite Rating. Its EPS Rating is 75, which is more beneficial.
For the latest Marijuana Stocks News, articles and reports make sure you are subscribed to MarijuanaStocks.com
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | email@example.com